Yarrow Bioscience YARW
NASDAQ YARW
$37.93 -2.67 (-6.58%)
At close: Aug 20, 2026 · 4:00 PM EDT

Yarrow Bioscience (YARW) Minority Interest (2022)

Yarrow Bioscience's (YARW) quarterly Minority Interest came in at $211000.0 in Q4 2022.

Yarrow Bioscience (YARW) Minority Interest (2022) Analysis & Trends

Yarrow Bioscience (YARW) has 1 years of Minority Interest data on file, last reported at $211000.0 in Q4 2022.

  • Quarterly Minority Interest changed N/A year-over-year to $211000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $211000.0 (changed N/A YoY) and the FY2022 annual result came in at $211000.0, changed N/A from the prior year.
  • Minority Interest steadied at $211000.0 in Q4 2022.
  • In the past five years, Minority Interest ranged from a high of $211000.0 in Q4 2022 to a low of $211000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Yarrow Bioscience 32.54 Mn 9.62 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 211,000.00